American Century Companies Inc Aerie Pharmaceuticals Inc Transaction History

American Century Companies Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$11.84 - $25.52 $1.72 Million - $3.7 Million	-144,877 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$17.72 - $25.1 $516,662 - $731,840	29,157 Added 25.2%	144,877 $3.5 Million
Q3 2019 Nov 13, 2019	BUY	$18.41 - $28.0 $128,593 - $195,580	6,985 Added 6.42%	115,720 $2.22 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $716,138 - $1.19 Million	24,720 Added 29.42%	108,735 $3.21 Million
Q1 2019 May 14, 2019	SELL	$36.32 - $49.25 $196,636 - $266,639	-5,414 Reduced 6.05%	84,015 $0
Q4 2018 Feb 13, 2019	BUY	$33.0 - $60.04 $510,576 - $928,938	15,472 Added 20.92%	89,429 $3.23 Million
Q3 2018 Nov 02, 2018	BUY	$56.15 - $73.9 $106,685 - $140,410	1,900 Added 2.64%	73,957 $4.55 Million
Q2 2018 Aug 08, 2018	BUY	$47.85 - $70.45 $752,106 - $1.11 Million	15,718 Added 27.9%	72,057 $4.87 Million
Q1 2018 May 03, 2018	BUY	$51.15 - $61.0 $1.16 Million - $1.39 Million	22,751 Added 67.74%	56,339 $3.06 Million
Q4 2017 Feb 02, 2018	BUY	$50.85 - $65.1 $475,549 - $608,815	9,352 Added 38.59%	33,588 $2.01 Million
Q3 2017 Nov 01, 2017	BUY	$48.6 - $60.1 $1.18 Million - $1.46 Million	24,236	24,236 $1.18 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.